Skip to main content
Premium Trial:

Request an Annual Quote

BD AbSeq Assay

Becton Dickinson has announced the commercial release of its BD AbSeq assay, which will analyze protein expression at the single-cell level using high-throughput sequencing. The assay integrates high-quality antibodies from the BD Pharmingen portfolio with oligonucleotides, allowing researchers to perform single-cell analysis on the firm's Rhapsody single-cell analysis system. When used in tandem, the tools allow researchers to simultaneously analyze RNA and proteins in thousands of individual cells and develop a clearer picture of the role genes and proteins play in biological systems. 

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more